New Cellulose-Based Biomaterial For 3D Printing and Molding of Medical Devices

摘要

FibreTuff, West Unity, Ohio, recently launched compounding operations to manufacture a cellulose-based biomaterial for 3D printing and molding of Class I and II medical devices for spine, trauma and sports medicine. The company expects to hire about 20 people over the next three years as companies across the U.S. begin to use FibreTuff PAPC filaments and powders for 3D printing.